20,000 cancer patients to get genetic profiling in hunt for new treatments
NCT ID NCT04932525
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study will collect blood and tumor samples from 20,000 adults with solid tumors to perform detailed genetic analysis. The goal is to find how many patients have at least one genetic change that could be targeted by existing or experimental therapies. This is a research study, not a treatment, and aims to improve future cancer care by identifying more personalized treatment options.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help identify more genetic targets for cancer treatments, potentially leading to personalized therapies for many patients.
What could go wrong
This is an observational study, not a treatment trial. It may not directly benefit participants, and finding a targetable alteration does not guarantee an effective therapy exists.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR, UNSPECIFIED, ADULT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Gustave Roussy Cancer Campus Grand Paris
RECRUITINGVillejuif, Val de Marne, 94805, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Foch
NOT_YET_RECRUITINGSuresnes, 92150, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Marie-Lannelongue
RECRUITINGLe Plessis-Robinson, 92350, France
Contact Email: •••••@•••••
-
Hôpital Saint-Joseph
NOT_YET_RECRUITINGParis, 75014, France
Contact Phone: •••-•••-•••• Email: •••••@•••••